EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pituitary Apoplexy Following Gonadotropin‐Releasing Hormone Agonist Administration for Prostate Cancer

Masaaki Fujimura iD, Takahiro Shimizu, Shinichi Sakamoto, Hiroaki Sato iD, Hiroyoshi Suzuki, Kazuo Mikami

IJU Case Reports · 2026-03 · 9 (2)

DOI: 10.1002/iju5.70159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IJU Case Reports, online erschienen am 27.02.2026. Verfasst von Masaaki Fujimura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology Chibaken Saiseikai Narashino Hospital Chiba Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pituitary apoplexy represents an uncommon endocrine emergency with potentially life‐threatening consequences. Gonadotropin‐releasing hormone agonist used for prostate cancer has the potential to induce pituitary apoplexy, particularly in the setting of a preexisting pituitary adenoma. Case Presentation A 76‐year‐old male with prostate cancer initially chose active surveillance; however, prostate‐specific antigen (PSA) elevation required hormonal therapy 5 years later. A pancreatic islet tumor had been previously identified; however, its details were unavailable. He was presented to the emergency department 24 h after receiving the first gonadotropin‐releasing hormone agonist injection. He showed severe headache, general fatigue, diplopia, and ptosis of the right eye. Brain MRI revealed a right deviated suprasellar pituitary adenoma with hemorrhagic infarction. He was conservatively treated with high‐dose steroids; symptoms improved within 1 week.

Conclusion

Clinicians should be aware of the association of pituitary apoplexy with the use of gonadotropin‐releasing hormone agonist and should ask about the patient's past history of multiple endocrine neoplasia (MEN).

Schlagwörter

Stichwörter der Autor:innen

gonadotropin‐releasing hormone agonistpituitary apoplexyprostate cancer

Autor:innen und Institutionen

  • Department of Urology Chibaken Saiseikai Narashino Hospital Chiba Japan.
  • Department of Urology Chiba University Chiba Japan.
  • Department of Urology Toho University Medical Center Sakura Hospital Chiba Japan.

ORCID-Profile: Masaaki Fujimura, Hiroaki Sato

Zitieren

APA

Fujimura, M., Shimizu, T., Sakamoto, S., Sato, H., Suzuki, H., & Mikami, K. (2026). Pituitary Apoplexy Following Gonadotropin‐Releasing Hormone Agonist Administration for Prostate Cancer. IJU Case Reports, 9(2). https://doi.org/10.1002/iju5.70159

Vancouver

Fujimura M, Shimizu T, Sakamoto S, Sato H, Suzuki H, Mikami K. Pituitary Apoplexy Following Gonadotropin‐Releasing Hormone Agonist Administration for Prostate Cancer. IJU Case Reports. 2026;9(2). doi:10.1002/iju5.70159

BibTeX
@article{Fujimura2026,
  author = {Fujimura, Masaaki and Shimizu, Takahiro and Sakamoto, Shinichi and Sato, Hiroaki and Suzuki, Hiroyoshi and Mikami, Kazuo},
  title = {Pituitary Apoplexy Following Gonadotropin‐Releasing Hormone Agonist Administration for Prostate Cancer},
  journal = {IJU Case Reports},
  year = {2026},
  volume = {9},
  number = {2},
  doi = {10.1002/iju5.70159}
}
Kostenlos starten →